Mansoor Abdul1, Arben Santo, Naseema Hoosein. 1. Edward Via Virginia College of Osteopathic Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA.
Abstract
BACKGROUND: Potassium ion (K+) channels are known to play a key role in breast cancer proliferation. MATERIALS AND METHODS: We investigated the expression of Kv1.3 voltage-gated K+ channels in 60 human breast cancer specimens by immunohistochemistry. The effects of K+ channel-blockers on cellular proliferation were examined in vitro. RESULTS: No immunostaining was observed in 4 normal human breast specimens. Eighteen (30%) breast cancer specimens showed high, 35 (58%) moderate and 7 (12%) low Kv1.3 staining in the epithelial compartment. Minoxidil (K+ channel-opener) stimulated growth of MCF-7 human breast cancer cells (maximal approximately 60% at 10 micrograms/mL). K+ channel-blockers, dequalinium and amiodarone, had marked inhibitory effects on MCF-7 proliferation (> 90% inhibition at 1.5 micrograms/mL). Importantly, amiodarone and dequalinium potentiated the growth-inhibitory effects of tamoxifen on human breast (MCF-7, MDA-MB-231) as well as prostate (PC3, MDA-PCA-2B) and colon (Colo320DM, SW1116) cancer cell lines. CONCLUSION: Investigation of combination therapy with tamoxifen and K+ channel-blockers is warranted.
BACKGROUND: Potassium ion (K+) channels are known to play a key role in breast cancer proliferation. MATERIALS AND METHODS: We investigated the expression of Kv1.3 voltage-gated K+ channels in 60 humanbreast cancer specimens by immunohistochemistry. The effects of K+ channel-blockers on cellular proliferation were examined in vitro. RESULTS: No immunostaining was observed in 4 normal human breast specimens. Eighteen (30%) breast cancer specimens showed high, 35 (58%) moderate and 7 (12%) low Kv1.3 staining in the epithelial compartment. Minoxidil (K+ channel-opener) stimulated growth of MCF-7 humanbreast cancer cells (maximal approximately 60% at 10 micrograms/mL). K+ channel-blockers, dequalinium and amiodarone, had marked inhibitory effects on MCF-7 proliferation (> 90% inhibition at 1.5 micrograms/mL). Importantly, amiodarone and dequalinium potentiated the growth-inhibitory effects of tamoxifen on human breast (MCF-7, MDA-MB-231) as well as prostate (PC3, MDA-PCA-2B) and colon (Colo320DM, SW1116) cancer cell lines. CONCLUSION: Investigation of combination therapy with tamoxifen and K+ channel-blockers is warranted.
Authors: R Sarzani; F Pietrucci; M Francioni; F Salvi; C Letizia; E D'Erasmo; P Dessì Fulgheri; A Rappelli Journal: J Endocrinol Invest Date: 2006-02 Impact factor: 4.256
Authors: Špela Gubič; Louise A Hendrickx; Žan Toplak; Maša Sterle; Steve Peigneur; Tihomir Tomašič; Luis A Pardo; Jan Tytgat; Anamarija Zega; Lucija P Mašič Journal: Med Res Rev Date: 2021-05-01 Impact factor: 12.944
Authors: In Young Kim; You Jung Kang; Mi Jin Yoon; Eun Hee Kim; Seung U Kim; Taeg Kyu Kwon; In Ah Kim; Kyeong Sook Choi Journal: Neuro Oncol Date: 2011-02-03 Impact factor: 12.300